These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 3626614
1. Blood and spleen haematopoiesis in patients with myelofibrosis. Douay L, Laporte JP, Lefrancois G, Najman A, Dupuy-Montbrun MC, Lopez M, Giarratana MC, Gorin NC. Leuk Res; 1987; 11(8):725-30. PubMed ID: 3626614 [Abstract] [Full Text] [Related]
3. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia. Mesa RA, Li CY, Schroeder G, Tefferi A. Blood; 2001 Jun 01; 97(11):3665-7. PubMed ID: 11369668 [Abstract] [Full Text] [Related]
4. Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia. Sagaster V, Jäger E, Weltermann A, Schwarzinger I, Gisslinger H, Lechner K, Geissler K, Oehler L. Haematologica; 2003 Nov 01; 88(11):1204-12. PubMed ID: 14607748 [Abstract] [Full Text] [Related]
6. [Studies on the haematopoietic stem cells in primary myelofibrosis--in vitro colony forming capacity of the peripheral blood, the spleen, the splenic arterial and venous blood (author's transl)]. Yamaguchi A, Yoshida K, Fukuda M, Fukushima Y, Sano M, Shibata A. Rinsho Ketsueki; 1978 Mar 01; 19(3):221-5. PubMed ID: 702808 [No Abstract] [Full Text] [Related]
7. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. Wang X, Prakash S, Lu M, Tripodi J, Ye F, Najfeld V, Li Y, Schwartz M, Weinberg R, Roda P, Orazi A, Hoffman R. J Clin Invest; 2012 Nov 01; 122(11):3888-99. PubMed ID: 23023702 [Abstract] [Full Text] [Related]
12. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients. Wang X, Cho SY, Hu CS, Chen D, Roboz J, Hoffman R. Exp Hematol; 2015 Feb 01; 43(2):100-9.e1. PubMed ID: 25461253 [Abstract] [Full Text] [Related]
20. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA. Bone Marrow Transplant; 1994 Dec 20; 14(6):877-84. PubMed ID: 7536069 [Abstract] [Full Text] [Related] Page: [Next] [New Search]